0000929638-26-000953.txt : 20260310 0000929638-26-000953.hdr.sgml : 20260310 20260310153733 ACCESSION NUMBER: 0000929638-26-000953 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260310 DATE AS OF CHANGE: 20260310 EFFECTIVENESS DATE: 20260310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioImpact Equities Fund, LP CENTRAL INDEX KEY: 0001807882 ORGANIZATION NAME: EIN: 272503747 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-363866 FILM NUMBER: 26738909 BUSINESS ADDRESS: STREET 1: 399 BOYLSTON STREET, SUITE 1100 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-410-4777 MAIL ADDRESS: STREET 1: 399 BOYLSTON STREET, SUITE 1100 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Burrage Capital Healthcare Fund I, LP DATE OF NAME CHANGE: 20200326 D/A 1 primary_doc.xml X0708 D/A LIVE 0001807882 BioImpact Equities Fund, LP 399 BOYLSTON STREET, SUITE 1100 BOSTON MA MASSACHUSETTS 02116 617-410-4770 DELAWARE None Burrage Capital Healthcare Fund I, LP Limited Partnership true n/a BioImpact Equities LLC 399 Bolyston Street, Suite 1100 Boston MA MASSACHUSETTS 02116 Executive Officer The General Partner of the Issuer. Christiana Goh Bardon 399 Boylston Street, Suite 1100 Boston MA MASSACHUSETTS 02116 Executive Officer Dr. Bardon is the Managing Member of the General Partner of the Issuer and the Co-Managing Partner of BioImpact Capital LLC, the Investment Manager of the Issuer. Kristen Laguerre 399 Boylston Street, Suite 1100 Boston MA MASSACHUSETTS 02116 Executive Officer Ms. Laguerre is the Partner, Finance and Operations Director and Authorized Signatory of the General Partner of the Issuer Christopher Wolf 399 Boylston Street, Suite 1100 Boston MA MASSACHUSETTS 02116 Executive Officer Mr. Wolf is the Chief Financial Officer and Authorized Signatory of the General Partner of the Issuer Pooled Investment Fund Hedge Fund false Decline to Disclose 06b true 0001567619-23-004655 2011-01-01 true true true Limited Partnership Interests. The General Partner, in its sole and absolute discretion, may accept investments of less than the $1,000,000 minimum. false 0 Indefinite 125453844 Indefinite The total amount sold and number of investors reflect only sales to residents of the U.S. and do not take redemptions and/or withdrawals into consideration. false 93 0 0 0 true Certain persons named in Item 3 or affiliates thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amount of such payments cannot be estimated at this time. false BioImpact Equities Fund, LP /s/ Christopher Wolf Christopher Wolf Authorized Signatory of the General Partner of the Issuer 2026-03-09